Navigation Links
American Heart Association Late-Breaking Clinical Trial Report: New Reversible Oral Drug Reduces Cardiac Events in Primary PCI Patients
Date:11/15/2009

eceptor so that the drug does not bind permanently to the receptor, and the receptor and the platelet can regain function, with normal platelet clotting ability returning in about four days, which may explain the absence of increased bleeding with ticagrelor," Steg said. "However, ticagrelor does have off-target effects, which probably explain a side effect more commonly seen with ticagrelor than clopidogrel: dyspnea, or breathlessness, which affected 12.9 percent of ticagrelor patients and 8.3 percent of the clopidogrel group."

Overall mortality was reduced with ticagrelor -- from 6.0 percent to 4.9 percent, a relative reduction of risk of 18 percent. Likewise, the risk of new myocardial infarction and the risk of stent thrombosis were also reduced. "Furthermore, the benefit is not solely achieved during the acute phase, the first 30 days after angioplasty, but the benefit accrues over time so that the longer you treat, the greater the difference in event rates," Steg said. "There is a strong rationale to prefer this new agent both in the acute (first 30 days) and in the late phase after a heart attack."

Study funded by: AstraZeneca (manufacturer of the investigational drug).

Co-authors are: Richard C. Becker, M.D.; Christopher P. Cannon, M.D.; Hakan Emanuelsson, M.D., Ph.D.; Robert A. Harrington, M.D.; Jay Horrow, M.D.; Steen Husted, M.D., D.Sc.; Hugo Katus, M.D.; Robert F. Storey, M.D., D.M.; Lars C. Wallentin, M.D., Ph.D.

Disclosures: Research grant: Sanofi-Aventis, Servier Speakers bureau: Boehringer-Ingelheim, BMS, GSK, Medtronic, Sanofi-Aventis, Servier, The Medicines Company. Consulting/advisory board: Astellas, AstraZeneca, Bayer, Boehringer-Ingelheim, BMS, Endotis, GSK, Medtronic, MSD, Nycomed, Sanofi-Aventis, Servier, and The Medicines Company.

Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and
'/>"/>

SOURCE American Heart Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
4. Aspirin Named 8th World Wonder by Majority of Americans
5. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
7. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
8. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
9. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... and MENLO PARK, Calif. ... Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") today ... financial statements.  The Company recently changed its fiscal year ... application to list its common stock on a national ... DelMar,s financial statements as filed with the United States ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Orthopedic Soft Tissue Repair Devices Market 2014-2018" ... tissues are the mass of cells that connect, support, ... soft tissues such as tendons, ligaments, cartilage, fascia, and ... degeneration of these tissues with age result in wear ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire/ –  Royal ... AEX: PHIA) today announced its ... of Cardiology (ESC) Congress 2014 , where ... of its cardiology solutions serving clinicians and patients ... and diagnosis, to treatment, recovery ...
Breaking Medicine Technology:DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 2FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 3FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 4FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 5FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 6FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 7FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 8FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 9FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 10FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 11Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 2Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 3Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 4Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 5Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 6
(Date:9/1/2014)... Angeles (PRWEB) September 01, 2014 "Women ... These hormonal daily changes begin as early as ... of their lives negotiating the ups and downs of ... or thin or even healthy sizes seems to rage ... As a woman in her 40's begin to ...
(Date:9/1/2014)... Daily fruit consumption cuts the risk of cardiovascular disease ... at ESC Congress today by Dr Huaidong Du from ... study of nearly 0.5 million people in the China ... the more their risk of CVD declined. , Dr ... stroke, is the leading cause of death worldwide. Improving ...
(Date:9/1/2014)... 01, 2014 The National Association of ... that Dawn Bazarko, DNP, MPH, RN, and Adriana Perez, ... American Academy of Nursing. They will be inducted with ... FACHE, whose induction we reported last May. , Our ... during the 2014 American Academy of Nursing Policy Conference ...
(Date:9/1/2014)... September 01, 2014 In honor of National Take ... 22, Animal Emergency & Referral Center of Minnesota (AERC) is offering ... priority for their cats. , Many people don’t take their cat ... of a hassle,” but they wouldn’t decide not to take their ... a cavity. The same goes for pets. Just like people want ...
(Date:9/1/2014)... 01, 2014 Top10BestSEOHosting.com has recently ... web host suppliers carefully, Top10BestSEOHosting.com is here to ... best web hosting suppliers in 2014. , JustHost ... with a top-of-the-line shared hosting plan. The company’s ... platform that is affordable, accessible and powerful enough ...
Breaking Medicine News(10 mins):Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 2Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 3Health News:Fruit consumption cuts CVD risk by up to 40 percent 2Health News:Fruit consumption cuts CVD risk by up to 40 percent 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 4Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 3Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2
... PARS ) announced today it is undertaking ... optimize the balance between cash,resources and its most ... involves a workforce reduction from 23 to 8,employees ... does not,expect a material charge against operations to ...
... 30, 2007 Researchers from the University of California, ... the University of California, San Francisco; and the University ... only linked to childhood obesity, but also to hypertension ... December 2007 issue of the American Journal of Preventive ...
... at launch, due to its First To File ... ... owned subsidiary of Ranbaxy Laboratories Limited (RLL),announced today that RLL has received tentative ... 40 mg,80 mg, 160 mg and 320 mg. Total annual market sales for ...
... DIEGO, Oct. 29 Genoptix, Inc. announced,today the pricing ... stock at a price of $17.00 per share. 4,285,714 ... being offered by certain selling,stockholders. In addition, Genoptix and ... option to purchase up to an additional,750,000 shares of ...
... Wis., Oct. 29 TenderCare,International, Inc. (OTC. Bulletin Board: ... October 24, 2007, with The Hain Celestial,Group, Inc. (Nasdaq: ... and personal,care products company. Under the terms of the ... in cash for all of the outstanding shares of,TenderCare ...
... (NYSE:,VTR) ("Ventas" or the "Company") said today that ... Senior Vice President -- Senior Housing Development,and Operations. ... President,and Chief Investment Officer. "Lisa is uniquely ... her proven record of successfully operating and growing,businesses ...
Cached Medicine News:Health News:Pharmos Restructures Operations in Israel 2Health News:Pharmos Restructures Operations in Israel 3Health News:Study links hypertension in obese children to television viewing 2Health News:Ranbaxy Receives Tentative Approval For Valsartan Tablets 2Health News:Genoptix, Inc. Announces Pricing for Initial Public Offering 2Health News:TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock 2Health News:Ventas Appoints Brush SVP - Senior Housing Development and Operations 2Health News:Ventas Appoints Brush SVP - Senior Housing Development and Operations 3Health News:Ventas Appoints Brush SVP - Senior Housing Development and Operations 4Health News:Ventas Appoints Brush SVP - Senior Housing Development and Operations 5
... pacemaker family offers some ... automatic devices. Featuring the ... advanced technologies ever seen, ... incorporates the exclusive ventricular ...
... The Guidant INSIGNIA ... sophisticated patient-specific, easy-to-use features ... and enhanced patient safety. ... are programmed using the ...
... model 1688 and model 1488 active-fixation leads ... leads, offering the unsurpassed handling advantages, performance, ... line of active-fixation leads. Implantable with a ... of the Tendril SDX lead is designed ...
... FlashLink Wireless is a stand-alone real-time ... provides for user defined set up, ... for temperature and humidity. It offers ... as hospitals, blood banks, laboratories, refrigerators, ...
Medicine Products: